Correlation Between Nuvectis Pharma and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Nuvectis Pharma and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Biomarin Pharmaceutical.
Diversification Opportunities for Nuvectis Pharma and Biomarin Pharmaceutical
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Nuvectis and Biomarin is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Biomarin Pharmaceutical
Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 3.23 times more return on investment than Biomarin Pharmaceutical. However, Nuvectis Pharma is 3.23 times more volatile than Biomarin Pharmaceutical. It trades about 0.0 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.06 per unit of risk. If you would invest 844.00 in Nuvectis Pharma on September 2, 2024 and sell it today you would lose (340.00) from holding Nuvectis Pharma or give up 40.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvectis Pharma vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Nuvectis Pharma |
| Biomarin Pharmaceutical |
Nuvectis Pharma and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvectis Pharma and Biomarin Pharmaceutical
The main advantage of trading using opposite Nuvectis Pharma and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |